Considering adding sexual hormone therapy to your practice? DrWell can help! In this DrWell subscriber-only webinar, Jennifer Cooper, APRN and DrWell Chief Nursing Officer will provide an overview of therapy for men and women, what labs your should draw and the starting doses for medications to incorporate into your existing weight and wellness program.  …

🎉 Big News: We’ve Lowered Prescription Rates with Our Partner Pharmacies At DrWell, your patients’ well-being is our top priority—and that includes making their care more affordable. We’re excited to announce that prescription prices through our partner pharmacies are now even lower. Thanks to new agreements with our pharmacy network, your patients can access the…

The Recommended Items feature empowers providers to strategically suggest additional, relevant programs to patients at the moment of peak engagement—right after checkout. By surfacing curated follow-up or complementary programs, providers can:   🔼 Increase Revenue per Patient Patients are more likely to enroll in multiple programs when presented with logical next steps immediately after purchase. This feature helps convert…

We’re excited to announce our new Facebook group exclusively for providers—a space to connect, share ideas, marketing tips, and clinical insights that help all of us succeed. What to expect: • Marketing tips to help you grow your practice • Community support and insights from fellow DrWell providers • A place to ask questions, collaborate,…

According to this Medscape article, recent research is shining a spotlight on an unexpected benefit of GLP‑1 receptor agonists (GLP‑1 RAs) weight loss medications: they may help improve chronic inflammatory skin conditions, such as psoriasis, hidradenitis suppurativa (HS), and even wound healing . From Diabetes to Dermatology Originally developed to manage type 2 diabetes, GLP‑1 RAs (e.g., semaglutide,…

The surge in GLP-1 medications like semaglutide and tirzepatide is not only revolutionizing weight management but also reshaping the medical aesthetics industry.   A recent McKinsey study has revealed that 63% of patients pursuing aesthetic treatments after starting GLP-1s had never received any aesthetics procedure before.   These patients are entering the market with fresh…